Literature DB >> 11606727

Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase.

Z Q Zhou1, D Manguino, K Kewitt, G W Intano, C A McMahan, D C Herbert, M Hanes, R Reddick, Y Ikeno, C A Walter.   

Abstract

O(6)-methylguanine (O(6)mG) is a potent mutagenic and procarcinogenic DNA lesion. Organisms have evolved with a DNA repair mechanism that largely ameliorates the deleterious effects of O(6)mG through a direct reversal mechanism by a protein termed O(6)-methylguanine-DNA methyltransferase (MGMT). However, the contribution of O(6)mG to carcinogenesis, in the absence of known exposure to agents that produce it, has not been defined. Nontransgenic C3HeB male mice have a high frequency of spontaneous liver tumors. Transgenic CeHeB/FeJ mice expressing human MGMT (hMGMT) were generated that had elevated hepatic MGMT activity. The spontaneous development of hepatocellular carcinoma was significantly reduced in those mice expressing hMGMT compared with nontransgenic C3HeB/FeJ male mice. No differences were detected in spontaneous mutant frequencies in lacI transgenes in mice carrying hMGMT compared with that without hMGMT but the proportion of GC to AT transition mutations was lower in the transgenic mice carrying hMGMT as well as lacI. Tumors that arose in C3HeB/FeJ transgenic mice were largely deficient in hMGMT protein as determined by immunohistochemistry with a monoclonal antibody directed against hMGMT. Together these data indicate that spontaneous O(6)mG lesions induced hepatocellular carcinogenesis in C3HeB/FeJ male mice. These transgenic mice represent a rare example of reduced spontaneous carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606727      PMCID: PMC60094          DOI: 10.1073/pnas.221232998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Comparison of the mutagenic properties of 8-oxo-7,8-dihydro-2'-deoxyadenosine and 8-oxo-7,8-dihydro-2'-deoxyguanosine DNA lesions in mammalian cells.

Authors:  X Tan; A P Grollman; S Shibutani
Journal:  Carcinogenesis       Date:  1999-12       Impact factor: 4.944

Review 2.  CpG islands in chromatin organization and gene expression.

Authors:  T K Kundu; M R Rao
Journal:  J Biochem       Date:  1999-02       Impact factor: 3.387

3.  Repair of alkylated DNA in Escherichia coli. Physical properties of O6-methylguanine-DNA methyltransferase.

Authors:  B Demple; A Jacobsson; M Olsson; P Robins; T Lindahl
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

4.  O6-alkylguanine alkyl acceptor protein activity in hepatocytes of C3H and C57BL mice during dimethylnitrosamine exposure.

Authors:  C Lindamood; M A Bedell; K C Billings; M C Dyroff; J A Swenberg
Journal:  Chem Biol Interact       Date:  1983-08-01       Impact factor: 5.192

5.  Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis.

Authors:  K Becker; J Dosch; C M Gregel; B A Martin; B Kaina
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

6.  Focal impairment of growth in hepatocellular neoplasms of C57BL/6 mice: a possible explanation for the strain's resistance to hepatocarcinogenesis.

Authors:  S Kakizoe; S Goldfarb; T D Pugh
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

7.  Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell.

Authors:  L Liu; X Qin; S L Gerson
Journal:  Carcinogenesis       Date:  1999-02       Impact factor: 4.944

8.  Inhibition of human O6-methylguanine-DNA methyltransferase by 5-methylcytosine.

Authors:  S S Bentivegna; E Bresnick
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

9.  Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.

Authors:  Y Canitrot; C Cazaux; M Fréchet; K Bouayadi; C Lesca; B Salles; J S Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

10.  Dose response for DNA alkylation, [3H]thymidine uptake into DNA, and O6-methylguanine-DNA methyltransferase activity in hepatocytes of rats and mice continuously exposed to dimethylnitrosamine.

Authors:  C Lindamood; M A Bedell; K C Billings; M C Dyroff; J A Swenberg
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

View more
  14 in total

1.  Age-related instability in spermatogenic cell nuclear and mitochondrial DNA obtained from Apex1 heterozygous mice.

Authors:  Kristine S Vogel; Marissa Perez; Jamila R Momand; Karina Acevedo-Torres; Kim Hildreth; Rebecca A Garcia; Carlos A Torres-Ramos; Sylvette Ayala-Torres; Thomas J Prihoda; C Alex McMahan; Christi A Walter
Journal:  Mol Reprod Dev       Date:  2011-09-14       Impact factor: 2.609

2.  BAX and tumor suppressor TRP53 are important in regulating mutagenesis in spermatogenic cells in mice.

Authors:  Guogang Xu; Kristine S Vogel; C Alex McMahan; Damon C Herbert; Christi A Walter
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

3.  S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis.

Authors:  Wei Wei; Bin Li; Martha A Hanes; Sanjay Kakar; Xin Chen; Limin Liu
Journal:  Sci Transl Med       Date:  2010-02-17       Impact factor: 17.956

Review 4.  Balancing repair and tolerance of DNA damage caused by alkylating agents.

Authors:  Dragony Fu; Jennifer A Calvo; Leona D Samson
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

5.  Repair of endogenous DNA base lesions modulate lifespan in mice.

Authors:  Lisiane B Meira; Jennifer A Calvo; Dharini Shah; Joanna Klapacz; Catherine A Moroski-Erkul; Roderick T Bronson; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2014-06-30

6.  S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver.

Authors:  James Leung; Wei Wei; Limin Liu
Journal:  Carcinogenesis       Date:  2013-01-25       Impact factor: 4.944

Review 7.  Prevention of liver cancer.

Authors:  Kathryn Z Guyton; Thomas W Kensler
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

8.  DNA Alkylating Agent Protects Against Spontaneous Hepatocellular Carcinoma Regardless of O6-Methylguanine-DNA Methyltransferase Status.

Authors:  Maryanne C S Herzig; Jessica A Zavadil; Karah Street; Kim Hildreth; Norman R Drinkwater; Traci Reddick; Damon C Herbert; Martha A Hanes; C Alex McMahan; Robert L Reddick; Christi A Walter
Journal:  Cancer Prev Res (Phila)       Date:  2015-12-14

9.  Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.

Authors:  A W Tolcher; S L Gerson; L Denis; C Geyer; L A Hammond; A Patnaik; A D Goetz; G Schwartz; T Edwards; L Reyderman; P Statkevich; D L Cutler; E K Rowinsky
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

10.  TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.

Authors:  Xiaoxin Mu; Shu Lin; Junhua Yang; Chen Chen; Yun Chen; Maryanne C Herzig; Kenneth Washburn; Glenn A Halff; Christi A Walter; Beicheng Sun; Lu-Zhe Sun
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.